Navigation Links
Transition Therapeutics Announces First Quarter Fiscal 2009 Financial Results
Date:11/10/2008

644,611

leasehold inducement (2,858) (2,858)

Stock-based compensation expense 643,548 324,790

Loss on disposal of capital assets 10,294 -

Unrealized foreign exchange (gain) loss (373,484) 15,497

Accrued interest on held-to-maturity

investments (174,597) (442,382)

Net change in operating assets and liabilities (1,015,958) (1,573,987)

-------------------------------------------------------------------------

Cash used in operating activities (5,112,104) (5,074,103)

-------------------------------------------------------------------------

INVESTING ACTIVITIES

Maturity of short-term investments 108,145,816 161,473,726

Purchase of short-term investments (98,473,182) (160,529,878)

Purchase of capital assets (43,317) (3,247)

Purchase of intangible assets (1,131,280) -

Proceeds on disposal of capital assets 48,161 -

-------------------------------------------------------------------------

Cash provided by investing activities 8,546,198 940,601

-------------------------------------------------------------------------

FINANCING ACTIVITY

Proceeds from issuance of common shares, net 125,551 24,038,446

-------------------------------------------------------------------------

Cash provided by financing activity 125,551 24,038,446

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Impact of foreign exchange on cash and cash

equivalents 372,996 (15,497)

---
'/>"/>

SOURCE Transition Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Respiratory Leaders Urge Medical Community to Educate Patients Transitioning CFC to HFA Inhalers
2. Transitions Optical to Provide Free Vision Screenings at the American Diabetes Associations Feria de Salud por tu Familia(TM)
3. Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2009 Financial Results on Monday, November 10th, at 4:30 P.M. EST
4. Schering-Plough Announces Transition of Animal Health Leadership
5. ACS Signs $27 Million Contract with Alaska to Transition Fiscal Agent Services for State Medicaid Program
6. MidSouth eHealth Alliance to Transition to Commercial Software Solution from Informatics Corporation of America
7. Transition Therapeutics Announces No Material Change
8. Transitions Optical Offers Tips on How to Protect Eyes for Outdoor Sports Fans
9. Transition Therapeutics Announces Executive Management Appointments
10. AGA Medical Announces Management Transition
11. Booth Radiology Associates Chooses IDC To Complete Its Transition To Digital Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2Water conserving irrigation strategies minimize overwatering runoff 60696 1Water conserving irrigation strategies minimize overwatering runoff 60696 2Water conserving irrigation strategies minimize overwatering runoff 60696 3When should flu trigger a school shutdown 3F 60692 1When should flu trigger a school shutdown 3F 60692 2When should flu trigger a school shutdown 3F 60692 3Cholesterol and Cancer 3A Answers and Some New Questions 60688 1Cholesterol and Cancer 3A Answers and Some New Questions 60688 2Cholesterol and Cancer 3A Answers and Some New Questions 60688 3Cholesterol and Cancer 3A Answers and Some New Questions 60688 4Cholesterol and Cancer 3A Answers and Some New Questions 60688 5